Royal Fund Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
LMFP
CIM
ATO
CGH
Royal Fund Management's GILD Position: Q2 2026 in Review
Royal Fund Management increased its Gilead Sciences (GILD) stake by 37% in Q2 2026, buying an estimated $91.8K and bringing the position to 2,573 shares worth $325K. The position accounts for 0.03% of the portfolio, ranked #244.
Royal Fund Management first reported a position in GILD in Q4 2016 and has held it in 22 quarters since. The position peaked at $2.09M in Q1 2018. 607 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Royal Fund Management held 2,573 shares of Gilead Sciences worth $325K as of Q2 2026.
- Royal Fund Management bought 697 Gilead Sciences shares in Q2 2026, an estimated $91.8K.
- Gilead Sciences made up 0.03% of Royal Fund Management's portfolio in Q2 2026, its #244 holding.
- Royal Fund Management first reported a position in Gilead Sciences in Q4 2016 and has held it in 22 quarters since.
- Royal Fund Management's Gilead Sciences position peaked at $2.09M in Q1 2018.
- 607 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Royal Fund Management's 13F filing for Q2 2026, filed 20 Jul 2026.